PATSY HOWELL: Open Payments
NPI 1609548767 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 74 payments from 22 companies in 2025. Trend: 2023 $141 · 2024 $798 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $328 |
| Daiichi Sankyo Inc. | 11 | $165 |
| ABBVIE INC. | 8 | $160 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Incyte Corporation | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Genmab U.S., Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 3 | $59 |
| Blueprint Medicines Corporation | 1 | $39 |
Products named: KISQALI, IMBRUVICA, DATROWAY, KEYTRUDA, Enhertu, SCEMBLIX, Epkinly, JAKAFI.
Industry payments across KY — which companies pay providers there.
